These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 28096086)

  • 1. Platelets activate a pathogenic response to blood-stage
    Gramaglia I; Velez J; Combes V; Grau GE; Wree M; van der Heyde HC
    Blood; 2017 Mar; 129(12):1669-1679. PubMed ID: 28096086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelets kill intraerythrocytic malarial parasites and mediate survival to infection.
    McMorran BJ; Marshall VM; de Graaf C; Drysdale KE; Shabbar M; Smyth GK; Corbin JE; Alexander WS; Foote SJ
    Science; 2009 Feb; 323(5915):797-800. PubMed ID: 19197068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-12 is required for antibody-mediated protective immunity against blood-stage Plasmodium chabaudi AS malaria infection in mice.
    Su Z; Stevenson MM
    J Immunol; 2002 Feb; 168(3):1348-55. PubMed ID: 11801675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelets kill circulating parasites of all major
    Kho S; Barber BE; Johar E; Andries B; Poespoprodjo JR; Kenangalem E; Piera KA; Ehmann A; Price RN; William T; Woodberry T; Foote S; Minigo G; Yeo TW; Grigg MJ; Anstey NM; McMorran BJ
    Blood; 2018 Sep; 132(12):1332-1344. PubMed ID: 30026183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insight into the Effects of Plasmodium chabaudi on Platelets Using Carbon-Fiber Microelectrode Amperometry.
    Xiong-Hang K; Kemnetz-Ness K; Krieger AC; Haynes CL
    ACS Infect Dis; 2019 Apr; 5(4):592-597. PubMed ID: 30712339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet depletion by anti-CD41 (alphaIIb) mAb injection early but not late in the course of disease protects against Plasmodium berghei pathogenesis by altering the levels of pathogenic cytokines.
    van der Heyde HC; Gramaglia I; Sun G; Woods C
    Blood; 2005 Mar; 105(5):1956-63. PubMed ID: 15494426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a Novel CD4
    Fernandez-Ruiz D; Lau LS; Ghazanfari N; Jones CM; Ng WY; Davey GM; Berthold D; Holz L; Kato Y; Enders MH; Bayarsaikhan G; Hendriks SH; Lansink LIM; Engel JA; Soon MSF; James KR; Cozijnsen A; Mollard V; Uboldi AD; Tonkin CJ; de Koning-Ward TF; Gilson PR; Kaisho T; Haque A; Crabb BS; Carbone FR; McFadden GI; Heath WR
    J Immunol; 2017 Dec; 199(12):4165-4179. PubMed ID: 29084838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD28 costimulation is required for the expression of T-cell-dependent cell-mediated immunity against blood-stage Plasmodium chabaudi malaria parasites.
    Rummel T; Batchelder J; Flaherty P; LaFleur G; Nanavati P; Burns JM; Weidanz WP
    Infect Immun; 2004 Oct; 72(10):5768-74. PubMed ID: 15385476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelets, pyrexia, and plasmodia.
    Greenbaum DC; FitzGerald GA
    N Engl J Med; 2009 Jul; 361(5):526-8. PubMed ID: 19641212
    [No Abstract]   [Full Text] [Related]  

  • 10. Gammadelta T cells but not NK cells are essential for cell-mediated immunity against Plasmodium chabaudi malaria.
    Weidanz WP; LaFleur G; Brown A; Burns JM; Gramaglia I; van der Heyde HC
    Infect Immun; 2010 Oct; 78(10):4331-40. PubMed ID: 20660608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ICAM-1 is a key receptor mediating cytoadherence and pathology in the Plasmodium chabaudi malaria model.
    Cunningham DA; Lin JW; Brugat T; Jarra W; Tumwine I; Kushinga G; Ramesar J; Franke-Fayard B; Langhorne J
    Malar J; 2017 May; 16(1):185. PubMed ID: 28468674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parasite-specific IgM plays a significant role in the protective immune response to asexual erythrocytic stage Plasmodium chabaudi AS infection.
    Couper KN; Phillips RS; Brombacher F; Alexander J
    Parasite Immunol; 2005 May; 27(5):171-80. PubMed ID: 15987340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Host Porphobilinogen Deaminase Deficiency Confers Malaria Resistance in
    Schnider CB; Yang H; Starrs L; Ehmann A; Rahimi F; Di Pierro E; Graziadei G; Matthews K; De Koning-Ward T; Bauer DC; Foote SJ; Burgio G; McMorran BJ
    Front Cell Infect Microbiol; 2020; 10():464. PubMed ID: 33014890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet-induced autoagglutination of Plasmodium falciparum-infected red blood cells and disease severity in Thailand.
    Chotivanich K; Sritabal J; Udomsangpetch R; Newton P; Stepniewska KA; Ruangveerayuth R; Looareesuwan S; Roberts DJ; White NJ
    J Infect Dis; 2004 Mar; 189(6):1052-5. PubMed ID: 14999609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasticity of immune responses suppressing parasitemia during acute Plasmodium chabaudi malaria.
    Weidanz WP; Kemp JR; Batchelder JM; Cigel FK; Sandor M; Heyde HC
    J Immunol; 1999 Jun; 162(12):7383-8. PubMed ID: 10358190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Taxol arrests the development of blood-stage Plasmodium falciparum in vitro and Plasmodium chabaudi adami in malaria-infected mice.
    Pouvelle B; Farley PJ; Long CA; Taraschi TF
    J Clin Invest; 1994 Jul; 94(1):413-7. PubMed ID: 7913713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impairment of protective immunity to blood-stage malaria by concurrent nematode infection.
    Su Z; Segura M; Morgan K; Loredo-Osti JC; Stevenson MM
    Infect Immun; 2005 Jun; 73(6):3531-9. PubMed ID: 15908382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of nitric oxide on the growth of Plasmodium falciparum, P. chabaudi and P. berghei in vitro.
    Balmer P; Phillips HM; Maestre AE; McMonagle FA; Phillips RS
    Parasite Immunol; 2000 Feb; 22(2):97-106. PubMed ID: 10652122
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Berretta F; Piccirillo CA; Stevenson MM
    Front Immunol; 2019; 10():425. PubMed ID: 30915078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of platelet adherence to brain microvasculature protects against severe Plasmodium berghei malaria.
    Sun G; Chang WL; Li J; Berney SM; Kimpel D; van der Heyde HC
    Infect Immun; 2003 Nov; 71(11):6553-61. PubMed ID: 14573677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.